Skip to content
OpenCapital
Get started

PMV Pharmaceuticals PMVP Q3 2025 earnings

Reported November 12, 2025 · Before market open

Diluted EPS-$0.40In line
EPS estimate-$0.40

Next report

Aug 6, 2026 (In 3 weeks)
EPS estimate-$0.38

Versus estimates

Diluted EPS

Q1 2026-$0.34Beat by $0.07Q4 2025-$0.34Beat by $0.06
Q3 2025-$0.40In line
Q2 2025-$0.41Miss by $0.02Q1 2025-$0.34Beat by $0.03Q4 2024-$0.45Miss by $0.07

Ask the moment PMV Pharmaceuticals reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did PMV Pharmaceuticals report Q3 2025 earnings?
PMV Pharmaceuticals (PMVP) reported Q3 2025 earnings on November 12, 2025 before market open.
What were PMV Pharmaceuticals's Q3 2025 revenue and EPS?
PMV Pharmaceuticals reported diluted EPS of $-0.40 for Q3 2025.
Did PMV Pharmaceuticals beat estimates in Q3 2025?
EPS beat the consensus estimate of $-0.40 by $0.00.
How did PMV Pharmaceuticals's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, diluted EPS declined 8.1% from $-0.37.
Where can I find PMV Pharmaceuticals's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-276000) and the 10-Q periodic report (0001193125-25-276003) directly on SEC EDGAR. The filing index links above go to sec.gov.